AIA Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.8M | Buy |
44,484
+10,255
| +30% | +$4.57M | 0.43% | 38 |
|
|
2025
Q1 | $16.6M | Buy |
34,229
+4,314
| +14% | +$2.09M | 0.41% | 41 |
|
|
2024
Q4 | $12M | Sell |
29,915
-871
| -3% | -$351K | 0.29% | 48 |
|
|
2024
Q3 | $14.3M | Buy |
30,786
+1,522
| +5% | +$708K | 0.37% | 41 |
|
|
2024
Q2 | $13.7M | Buy |
29,264
+4,898
| +20% | +$2.3M | 0.4% | 39 |
|
|
2024
Q1 | $10.2M | Buy |
24,366
+5,766
| +31% | +$2.41M | 0.33% | 39 |
|
|
2023
Q4 | $7.57M | Buy |
18,600
+1,512
| +9% | +$615K | 0.31% | 43 |
|
|
2023
Q3 | $5.94M | Buy |
17,088
+314
| +2% | +$109K | 0.29% | 44 |
|
|
2023
Q2 | $5.9M | Buy |
16,774
+8,977
| +115% | +$3.16M | 0.29% | 43 |
|
|
2023
Q1 | $2.46M | Buy |
7,797
+89
| +1% | +$28K | 0.13% | 64 |
|
|
2022
Q4 | $2.23M | Sell |
7,708
-1,925
| -20% | -$556K | 0.14% | 66 |
|
|
2022
Q3 | $2.79M | Sell |
9,633
-1,893
| -16% | -$548K | 0.18% | 52 |
|
|
2022
Q2 | $3.25M | Sell |
11,526
-955
| -8% | -$269K | 0.17% | 55 |
|
|
2022
Q1 | $3.26M | Buy |
12,481
+9,397
| +305% | +$2.45M | 0.14% | 63 |
|
|
2021
Q4 | $677K | Sell |
3,084
-2,981
| -49% | -$654K | 0.03% | 159 |
|
|
2021
Q3 | $1.1M | Buy |
+6,065
| New | +$1.1M | 0.06% | 137 |
|
|
2021
Q1 | – | Sell |
-1,767
| Closed | -$373K | – | 212 |
|
|
2020
Q4 | $373K | Buy |
+1,767
| New | +$373K | 0.04% | 142 |
|